Hormone therapy and peptide litigation sits at the intersection of endocrinology, pharmacology, and clinical standards that keep moving. When a case involves testosterone replacement, GLP-1 receptor agonists, BPC-157, or AI-assisted prescribing, a generalist medical expert rarely has the depth the case demands.
The witness needs to understand the science well enough to explain it plainly, the standard of care well enough to defend it under cross-examination, and the courtroom well enough to survive a Daubert challenge.
This guide walks attorneys through what credentials actually matter, why broad expert directories fall short for niche hormone cases, and how to vet a candidate before retention.
What Credentials Actually Matter for an Endocrinology Expert Witness
Board Certification Through ABIM
The baseline credential is board certification in endocrinology, diabetes, and metabolism through the American Board of Internal Medicine. ABIM certification requires passing a rigorous subspecialty examination after completing an accredited fellowship, with ongoing maintenance through continuing education and periodic recertification.
For hormone therapy and peptide litigation, ABIM certification signals that the witness has been independently evaluated on the clinical knowledge your case depends on. A self-described "hormone specialist" without it is a much easier target for opposing counsel at a Daubert hearing.
Peer-Reviewed Publications and Academic Standing
Published, peer-reviewed research demonstrates that the witness's opinions have been subjected to independent scientific scrutiny — which matters directly under Daubert. Courts applying that standard look at whether a methodology has been tested, whether it has been peer-reviewed, and whether it is generally accepted in the relevant scientific community.
An expert with a publication record in endocrinology, hormone physiology, or related pharmacology can point to that body of work when defending their methodology on the stand. Academic affiliation is a related signal: a witness who holds or has held a faculty appointment at a recognized institution has typically had their clinical reasoning reviewed by colleagues over time.
Active Clinical Practice
Credentials on paper mean little if the expert has not seen patients recently. The standard of care in hormone therapy and peptide cases is a moving target — GLP-1 agonists, peptide compounds, and regenerative medicine protocols have all evolved significantly, and a witness who stepped away from active practice several years ago may not be able to speak credibly to current prescribing norms. Look for an expert who continues to evaluate and treat patients with the conditions at issue in your case.
Courtroom and Deposition Experience
Credentials establish authority. Courtroom experience establishes effectiveness. An expert who has provided deposition testimony, written opinions for both plaintiff and defense counsel, and appeared at trial understands how to present complex endocrinology in terms a judge and jury can follow. They also know how opposing counsel will probe their methodology — and they are prepared for it.
Why Generalist Expert Directories Fall Short for Peptide and Hormone Cases
The Scope Problem with SEAK, JurisPro, and Similar Platforms
Platforms like SEAK and JurisPro serve a real function for common medical specialties. For a straightforward orthopedic injury or a general internal medicine case, a directory listing may surface a qualified candidate quickly. Hormone therapy and peptide litigation is not a common specialty area.
Most directory listings categorize experts at the level of "internal medicine" or "endocrinology" without distinguishing whether a candidate has any experience with testosterone replacement protocols, off-label peptide use, anabolic steroid toxicity, or AI-assisted clinical decision tools. When you retain someone from a broad listing, you often discover those gaps during deposition prep rather than before retention.
Niche Subject Matter Demands Specialist Depth
Cases involving peptides like BPC-157, TB-500, or CJC-1295 require an expert who understands not just endocrinology in general but the specific pharmacodynamics, regulatory status, and prescribing norms for those compounds. The same applies to anabolic steroid litigation, where the clinical picture involves complex hormonal suppression, cardiovascular risk, and sometimes off-label compounding practices.
Agentic AI in clinical settings adds another layer entirely. When an AI-assisted prescribing tool recommends a hormone dosing protocol and a patient is harmed, the standard of care analysis requires someone who understands both the clinical endocrinology and how AI systems interact with physician decision-making. That combination is not available through a general directory search.
Specialist Retained Practices vs. Directory Listings
| Factor | Generalist Directory | Specialist Retained Practice |
|---|---|---|
| Credential verification | Self-reported | Independently verifiable |
| Subject matter depth | Broad specialty category | Specific to hormone therapy, peptides, agentic AI |
| Opinion defensibility | Variable | Structured for Daubert review |
| Availability for both sides | Common | Selective, conflict-checked |
| Record review methodology | Inconsistent | Documented and reproducible |
| Courtroom experience | Listed but unverified | Demonstrated through prior engagements |
Attorney Checklist: Vetting an Endocrinology Expert Witness
Use this checklist before retaining any expert for hormone therapy or peptide litigation.
Credentials
- CheckboxABIM board certification in endocrinology, diabetes, and metabolism confirmed
- CheckboxActive clinical practice in the relevant subject area (hormone therapy, peptides, regenerative medicine)
- CheckboxPeer-reviewed publications in endocrinology or related pharmacology
- CheckboxAcademic affiliation or faculty appointment, current or recent
Case-Specific Fit
- CheckboxDirect experience with the compound or therapy at issue (testosterone, GLP-1 agonists, peptides, anabolic steroids)
- CheckboxFamiliarity with the prescribing context (telemedicine, compounding pharmacy, AI-assisted tools)
- CheckboxAbility to articulate the standard of care for the specific clinical scenario in your case
Opinion Quality
- CheckboxPrior written opinions available for review (redacted as needed)
- CheckboxMethodology is documented and reproducible
- CheckboxOpinion addresses causation, standard of care, and deviation specifically
- CheckboxExpert can explain the basis for each conclusion in plain language
Courtroom Readiness
- CheckboxDeposition and trial experience confirmed
- CheckboxRetained by both plaintiff and defense counsel in prior matters (demonstrates independence)
- CheckboxNo significant prior adverse Daubert rulings
Conflicts and Independence
- CheckboxConflict check completed
- CheckboxExpert does not have a financial relationship with parties, products, or manufacturers at issue
How a Record Review and Written Opinion Should Survive a Daubert Challenge
The Daubert Standard in Hormone Therapy Cases
Under Daubert v. Merrell Dow Pharmaceuticals, federal courts act as gatekeepers for expert testimony. The judge evaluates whether the expert's methodology is scientifically valid and whether it applies reliably to the facts of the case. In hormone therapy and peptide litigation, that means the opinion must rest on more than clinical intuition — it needs to cite recognized clinical guidelines, peer-reviewed literature, and a documented review of the specific medical records at issue.
An opinion that says "in my experience, this was below the standard of care" without grounding that conclusion in identifiable sources is vulnerable. An opinion that cites current endocrinology society guidelines, identifies the specific record entries supporting each conclusion, and explains how those facts map to the applicable standard is far harder to exclude.
What a Defensible Record Review Looks Like
A defensible record review starts with a complete set of medical records — not a summary provided by retaining counsel. The expert should document what records were reviewed, note any gaps, and identify the specific entries that bear on the standard of care question. The written opinion should then walk through the clinical timeline, explain what a reasonably competent endocrinologist would have done at each decision point, and state clearly where the care at issue deviated from or met that standard. Every conclusion needs a traceable basis in either the records or the published literature.
Opinions Involving Agentic AI in Clinical Settings
This is where methodology becomes especially important. When an AI system contributes to a clinical decision that results in harm, the standard of care analysis has to address both the physician's conduct and the role the AI tool played.
A qualified expert in this area needs to understand how agentic AI systems function in clinical workflows, what oversight obligations a prescribing physician carries when using such tools, and how current regulatory and professional guidance addresses AI-assisted prescribing. This is not a question a general internist or a technology consultant can answer alone. It requires an endocrinologist who has engaged with the clinical AI literature and can speak to both the medical and systems-level dimensions of the case.
Conclusion
Qualifying the right expert for hormone therapy and peptide litigation is not a checkbox exercise. It requires confirming ABIM board certification, active clinical practice in the relevant area, a peer-reviewed publication record, and demonstrated courtroom experience. Generalist directories can surface names — they cannot verify depth or methodology.
For cases involving testosterone replacement, peptide compounds, anabolic steroids, regenerative medicine, or AI-assisted prescribing, the expert's opinion needs to hold up under Daubert scrutiny and cross-examination. That standard demands a specialist, not a generalist who happens to list endocrinology as a category.
hormon.ai is the medicolegal practice of Dr. Fady Hannah-Shmouni, a board-certified endocrinologist providing independent expert witness services to plaintiff and defense counsel, insurers, and regulatory bodies in exactly these case types.